Chilivis Grubman LLP
  • Home
  • Firm Overview
  • Attorneys
    • Scott R. Grubman
    • Lauren A. Warner
    • Jeremy T. Berry
    • Brittany M. Cambre
    • Joseph J. Siegelman
    • Hakim Hilliard
    • Sanjay Karnik
    • Brandi Z. Murrain
    • Rachel N. Lugay
    • Maiysha Rashad
  • Practice Areas
    • Healthcare
      • Government Investigations & Litigation
      • Payor Audits and Audit Appeals
      • HIPAA and Cybersecurity
      • Medical Board Investigations
      • Peer Review & Credentialing Disputes
      • Healthcare Regulatory Compliance
    • Civil and Business Litigation
      • Class Action Defense
    • Criminal Defense
      • White Collar Crime
      • Healthcare Fraud
      • Public Corruption
      • Internal Investigations
    • False Claims Act and Qui Tam Defense
    • Data Privacy & Cybersecurity
    • Internal Investigations
    • Government Affairs
      • Advocacy and Regulatory Affairs
      • Government Contracts
      • Government Litigation and Administrative Law
      • Advertising Compliance
      • Land Use & Zoning
      • Licensing and Permits
    • Campaign Finance and Election Law
    • Entertainment Law & Artist Management
      • Trademark, Copyright, and Brand Protection
  • Blog
  • News
  • Insights
  • Contact
Select Page

Medical Device Manufacturer and Distributor Pay Combined $37 Million Under False Claims Act

Oct 5, 2025 | False Claims Act, Government Investigations, Health Care, Health Care Fraud, Medicare and Medicaid

On September 26, 2025, the Department of Justice announced that device manufacturer Semler Scientific had agreed to pay nearly $30 million, and its former distributor Bard Peripheral Vascular had agreed to pay an additional $7.2 million, in connection with the...

Knee Implant Manufacturer Agrees to $8 Million False Claims Act Settlement

Sep 17, 2025 | False Claims Act, Health Care, Health Care Fraud, Medicare and Medicaid

On September 16, 2025, the United States Attorney’s Office for the District of Maryland announced that knee implant manufacturer Exactech Inc. had agreed to pay $8 million to resolve allegations that it violated the False Claims Act (FCA). The press release...

HHS-OIG Expresses “Major Concerns” About Skin Substitutes

Sep 9, 2025 | Health Care, Health Care Fraud, Medicare and Medicaid

On September 8, 2025, the U.S. Department of Health & Human Services’ Office of Inspector General (HHS-OIG) issued a report expressing “major” fraud, waste, and abuse concerns related to skin substitutes billed to Medicare Part B. According to...

State False Claims Acts and Their Role in Fraud Enforcement

Aug 18, 2025 | False Claims Act, Fraud Investigations, Health Care, Health Care Fraud

We write frequently about the federal False Claims Act (FCA), which is the federal government’s most powerful civil fraud fighting tool. Healthcare providers, government contractors, and any other business that submits claims for reimbursement to the federal...

False Claims Act Risks for Healthcare Private Equity Investors

Aug 14, 2025 | False Claims Act, federal investigations, Health Care, Health Care Fraud, Healthcare Transactions

The federal False Claims Act (FCA) represents one of – if not the – top regulatory and liability risk that healthcare providers face when doing business with federal healthcare programs (FHPs) including Medicare and Medicaid. The FCA prohibits, among other things,...

Leading Medical Organizations Excluded from CDC’s Advisory Committee on Immunization Practices

Aug 11, 2025 | Health Care

Federal health leaders have excluded major medical organizations including the American Medical Association (AMA), the American Academy of Pediatrics (AAP), the American College of Physicians (ACP), and the Infectious Diseases Society of America (IDSA), from...
« Older Entries

Recent Posts

  • Medical Device Manufacturer and Distributor Pay Combined $37 Million Under False Claims Act
  • Knee Implant Manufacturer Agrees to $8 Million False Claims Act Settlement
  • Condo Conversion Planned for 2460 Peachtree Road
  • HHS-OIG Expresses “Major Concerns” About Skin Substitutes
  • DOJ & DHS Partner on Trade Fraud Task Force

Categories

  • A.I. Law
  • Accessory Dwelling Units
  • Administrative Law
  • Anti-Counterfeit
  • Atlanta News
  • Brand Protection
  • Business Litigation
  • Civil Healthcare Litigation
  • Civil Matters
  • Civil Rights
  • Code Enforcement
  • Commercial Litigation
  • Commercial Payor Audits
  • Complex Criminal Litigation
  • Copyright Infringement
  • COVID-19 Related Law
  • Criminal Matters
  • Cyber Law
  • Data Breach
  • DMEPOS
  • DOJ
  • Drug Policy Law
  • Election Law
  • Employment Law
  • Environmental
  • False Claims Act
  • federal investigations
  • Federal Tax Investigations
  • FINRA
  • Firm Announcement
  • FOIS Compliance
  • Fraud Investigations
  • General
  • Government Affairs
  • Government Contract
  • Government Investigations
  • Government Litigation
  • Health Care
  • Health Care Fraud
  • Healthcare Transactions
  • HIPAA
  • Housing Development Law
  • Land Use Law
  • Land Zoning Law
  • Liquor Law
  • Medicare and Medicaid
  • Non-Profit Organizations
  • ommercial payor audits
  • Open Records Act
  • Overpayment Appeals
  • PPP Investigations
  • Public Corruption
  • Restrictive Covenants
  • SEC Investigations
  • Special Use Permit Filing
  • State Bar of Georgia Investigations
  • Strategic Land Use
  • Tax Fraud
  • toxic tort
  • Trade Law
  • Trademark Enforcement
  • Trademark Protection
  • Tree Ordinance
  • Uncategorized
  • Variances
  • White Collar Crime
  • Zoning and Land Use
Built by The Montgomery Group